Upstate Active Clinical Trials
Study Title:RTOG 0839: Randomized Phase II Study of Pre-operative Chemoradiotherapy +/- Panitumumab (IND #110152) Followed by Consolidation Chemotherapy +/- Cetuximab in Potentially Operable Locally Advanced (Stage IIIA, N2+) Non-Small Cell Lung Cancer
What is the purpose of the study?This randomized phase II trial is studying chemotherapy and radiation therapy to see how well they work when given with or without panitumumab in treating patients with stage IIIA non-small cell lung cancer.
Upstate Institutional Review Board (IRB) Number:321567
Patient Age Group:Adults
Principal Investigator:Jeffrey A Bogart, MD
Who can I contact for more information?
Name: Dena R Martin